
AMN Stock Forecast & Price Target
AMN Analyst Ratings
Bulls say
AMN Healthcare Services Inc. reported second-quarter revenue of $658.2 million, representing a decrease of 11% year-over-year, but still exceeding estimates of $647.1 million and consensus expectations of $652.1 million. The company achieved a gross margin of 29.8%, which marked a sequential increase of 120 basis points, surpassing its guidance range of 28.5-29.0%. Furthermore, AMN demonstrated strong operational efficiency with an EBITDA of $58.3 million, which exceeded both internal estimates and consensus forecasts, highlighting an average revenue surprise of 3% and an average EBITDA surprise of 12% over the past four quarters.
Bears say
AMN Healthcare Services Inc. reported a decline in segment revenue across its major divisions, with nurse and allied solutions dropping by 9% year-over-year and physician and leadership solutions experiencing a 14% decrease. This reduction in revenue is compounded by a contraction in operating margins, with the nurse and allied solutions segment’s gross margin decreasing by 40 basis points sequentially, and an overall decline in VMS revenue of 31% year-over-year. Additionally, the average number of travelers on assignment decreased by 3% quarter-over-quarter, indicating potential challenges in sustaining workforce levels that can further impact revenue generation in the future.
This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.
AMN Analyst Forecast & Price Prediction
Start investing in AMN
Order type
Buy in
Order amount
Est. shares
0 shares